INTERLEUKIN-1 INDUCED NEUTROPHIL MEDIATED ARDS

INTERLEUKIN-1 诱导的中性粒细胞介导的 ARDS

基本信息

  • 批准号:
    6241999
  • 负责人:
  • 金额:
    $ 18.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-12-01 至 1997-11-30
  • 项目状态:
    已结题

项目摘要

For unknown reasons, patients wit ARDS have increased interleukin (IL-1), neutrophils, hydrogen peroxide (H202) and edema in their lungs and evidence of an altered lung and systemic oxidant-antioxidant balance. Our hypothesis is that toxic O2 radicals derived from xanthine oxidase (XO) and/or neutrophils contribute to lung leak in rats given IL-1 or ARDS patients. O2 radicals cause leak by peroxidizing lipids, oxidizing glutathione (GSH), inactivating antiprotease, and depleting vitamin E- processes which contribute to lung leak and further activate neutrophils. We propose that these events are associated with extracellular increases in SOD, catalase, XO, myeloperoxidase (MPO), GSSG and H2) which reflect and alter these processes. Our preliminary data supports this premise. Intratracheal IL-1 caused neutrophil accumulation and a neutrophil-dependent leak in lungs of intact rats which is associated with increased lung GSSG levels. Leak was decreased by treatment with DMSO, supercritical fluid aerosolized vitamin E, liposomal encapsulated PGE, or N-acetylcysteine-- in some cases even when these interventions are given after the IL-1 insult. IL-1 also caused leak and perfusate catalase increases in isolated lungs perfused with normal neutrophils but not heat-inactivated neutrophils which fail to make 02 radicals. In parallel, MnSOD, catalase and elastase-alpha1Pi complexes were increased in the blood of septic patients with ARDS compared to septic patients without ARDS. Our immediate specific aims are to determine the mechanisms responsible for lung leak in intact rats given IL-1 intratracheally or isolated IL-1 treated rat lungs perfused with neutrophils. Our investigations involve determination of the relationship of neutrophils, XO, oxidative injury and the appearance of extracellular markers in lungs treated with IL-1. Investigation also involves study of the effect of a carefully selected sequence of interventions that not only define these processes but also can potentially be used for treating ARDS patients. Parallel studies will evaluate neutrophils and serum from patients with and at risk for ARDS as a function of ARDS progression and intervention. The significance of these studies is (1) to improve understanding of fundamental mechanisms responsible for acute lung injury, (2) to gain new information regarding the predictive and functional value of extracellular markers and (3) to identify and define interventions which might be useful in treating or preventing ARDS.
由于未知的原因,患有ARDS的患者具有增加的白细胞介素(IL-1), 中性粒细胞、过氧化氢(H2 O2)和肺水肿, 肺部和全身氧化-抗氧化平衡改变的证据。 我们的假设是有毒的O2自由基来自黄嘌呤氧化酶 (XO)和/或嗜中性粒细胞导致给予IL-1或IL-2的大鼠的肺渗漏。 ARDS患者。 O2自由基通过过氧化脂质、氧化 谷胱甘肽(GSH),灭活抗蛋白酶,消耗维生素E- 这些过程导致肺渗漏并进一步激活嗜中性粒细胞。 我们认为,这些事件与细胞外的增加有关, 在SOD、过氧化氢酶、XO、髓过氧化物酶(MPO)、GSSG和H2)中, 并改变这些过程。 我们的初步数据支持这一假设。 肠内IL-1引起 中性粒细胞聚集和嗜中性粒细胞依赖性肺渗漏, 与肺GSSG水平增加相关的完整大鼠。 泄漏 DMSO、超临界流体雾化 维生素E、脂质体包封的PGE或N-乙酰半胱氨酸--在一些情况下 即使在IL-1损伤后给予这些干预措施的情况下。IL-1 也引起离体肺渗漏和灌注液过氧化氢酶增加 灌注正常中性粒细胞,但不灌注热灭活中性粒细胞 其不能产生O2自由基。 同时,MnSOD、过氧化氢酶和 弹性蛋白酶-α 1 Pi复合物在脓毒症患者血液中增加, 与无ARDS的脓毒症患者相比。 我们当前的具体目标是确定 对于气管内给予IL-1或分离的IL-1的完整大鼠的肺渗漏, 用中性粒细胞灌注的处理的大鼠肺。 我们的调查涉及 确定中性粒细胞、XO、氧化损伤的关系 以及用IL-1处理的肺中细胞外标记物的出现。 调查还包括研究一个精心挑选的 一系列干预措施,不仅定义了这些过程, 可以潜在地用于治疗ARDS患者。 平行研究 将评估患有和有风险的患者的中性粒细胞和血清 ARDS作为ARDS进展和干预的函数。 这些研究的意义在于(1)提高对 急性肺损伤的基本机制,(2)获得新的 关于预测和功能价值的信息, 细胞外标志物和(3)识别和定义干预, 可能有助于治疗或预防ARDS。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN E REPINE其他文献

JOHN E REPINE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN E REPINE', 18)}}的其他基金

Colorado Summer Research Training for Undergraduate Diversity
科罗拉多州本科生多样性夏季研究培训
  • 批准号:
    8681499
  • 财政年份:
    2011
  • 资助金额:
    $ 18.45万
  • 项目类别:
Colorado Summer Research Training for Undergraduate Diversity
科罗拉多州本科生多样性夏季研究培训
  • 批准号:
    8274337
  • 财政年份:
    2011
  • 资助金额:
    $ 18.45万
  • 项目类别:
Colorado Summer Research Training for Princeton and Notre Dame Undergraduate Dive
科罗拉多州普林斯顿大学和圣母大学本科潜水夏季研究培训
  • 批准号:
    8153693
  • 财政年份:
    2011
  • 资助金额:
    $ 18.45万
  • 项目类别:
Colorado Summer Research Training for Undergraduate Diversity
科罗拉多州本科生多样性夏季研究培训
  • 批准号:
    8525431
  • 财政年份:
    2011
  • 资助金额:
    $ 18.45万
  • 项目类别:
Colorado Summer Research Training for Undergraduate Diversity
科罗拉多州本科生多样性夏季研究培训
  • 批准号:
    10572302
  • 财政年份:
    2011
  • 资助金额:
    $ 18.45万
  • 项目类别:
INTERLEUKIN-1 INDUCED NEUTROPHIL MEDIATED ARDS
INTERLEUKIN-1 诱导的中性粒细胞介导的 ARDS
  • 批准号:
    6109915
  • 财政年份:
    1997
  • 资助金额:
    $ 18.45万
  • 项目类别:
MECHANISMS OF RESPIRATORY ENDOTHELIAL INJURY BY XO
XO 损伤呼吸内皮细胞的机制
  • 批准号:
    2222274
  • 财政年份:
    1992
  • 资助金额:
    $ 18.45万
  • 项目类别:
RESPIRATORY ENDOTHELIAL INJURY BY XANTHINE OXIDASE
黄嘌呤氧化酶引起的呼吸内皮损伤
  • 批准号:
    2028569
  • 财政年份:
    1992
  • 资助金额:
    $ 18.45万
  • 项目类别:
RESPIRATORY ENDOTHELIAL INJURY BY XANTHINE OXIDASE
黄嘌呤氧化酶引起的呼吸内皮损伤
  • 批准号:
    2685363
  • 财政年份:
    1992
  • 资助金额:
    $ 18.45万
  • 项目类别:
Respiratory Endothelial Injury by Xanthine Oxide
黄嘌呤氧化物引起的呼吸内皮损伤
  • 批准号:
    6621351
  • 财政年份:
    1992
  • 资助金额:
    $ 18.45万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 18.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.45万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 18.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 18.45万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 18.45万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 18.45万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 18.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 18.45万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 18.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 18.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了